Notice Information
Notice Title
Tender for the Supply of Services - Independent Central Review Of Primary Outcome Data For The GLO-BHNL Platform Clinical Trial - University Of Birmingham
Notice Description
The University of Birmingham invites tenders for independent central review of the primary outcome data for the clinical platform trial, Glo-BNHL. The platform aims to test a wide range of therapies over its lifetime in order to find better treatments for the rare paediatric cancer, B-cell non-Hodgkin's Lymphoma. The design allows addition of new treatment arms as novel therapies become available for testing. There are currently 2 treatment arms. Independent central review of the clinical data that informs the primary outcome measures is required, to include: cross sectional imaging by CT or MRI, PET-CT scan, bone marrow aspirate, bone marrow trephine and lumbar puncture pathology reports. Glo-BNHL is an international trial with participating sites in the UK, Europe, USA, Canada, Australia, New Zealand and Israel. A total of 45 sites will participate, with international sites' activity coordinated by 15 National Coordinating Centres. Glo-BNHL recently received ethics approval in the UK and will open later this year. Approval in the other participating nations will follow. An expedient solution to independent central review is therefore required. This project may be funded by the European Regional Development Fund (ERDF) or; - European Structural and Investment Fund (ESIF) or; - Research Councils UK (RCUK), the strategic partnership of the UK's seven Research Councils. Please refer to Appendix A via www.in-tendhost.co.uk/universityofbirmingham/aspx/Home for full specification of requirements.
Lot Information
Lot 1
The University of Birmingham invites tenders for independent central review of the primary outcome data for the clinical platform trial, Glo-BNHL. The platform aims to test a wide range of therapies over its lifetime in order to find better treatments for the rare paediatric cancer, B-cell non-Hodgkin's Lymphoma. The design allows addition of new treatment arms as novel therapies become available for testing. There are currently 2 treatment arms. Independent central review of the clinical data that informs the primary outcome measures is required, to include: cross sectional imaging by CT or MRI, PET-CT scan, bone marrow aspirate, bone marrow trephine and lumbar puncture pathology reports. Glo-BNHL is an international trial with participating sites in the UK, Europe, USA, Canada, Australia, New Zealand and Israel. A total of 45 sites will participate, with international sites' activity coordinated by 15 National Coordinating Centres. Glo-BNHL recently received ethics approval in the UK and will open later this year. Approval in the other participating nations will follow. An expedient solution to independent central review is therefore required. This project may be funded by the European Regional Development Fund (ERDF) or; - European Structural and Investment Fund (ESIF) or; - Research Councils UK (RCUK), the strategic partnership of the UK's seven Research Councils. Please refer to Appendix A via www.in-tendhost.co.uk/universityofbirmingham/aspx/Home for full specification of requirements.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-041a2f
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/033834-2023
- Current Stage
- Tender
- All Stages
- Tender
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
85 - Health and social work services
-
- CPV Codes
85150000 - Medical imaging services
Notice Value(s)
- Tender Value
- £5,000,000 £1M-£10M
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 15 Nov 20232 years ago
- Submission Deadline
- 15 Dec 2023Expired
- Future Notice Date
- Not specified
- Award Date
- Not specified
- Contract Period
- 30 Mar 2024 - 30 Mar 2031 Over 5 years
- Recurrence
- Not specified
Notice Status
- Tender Status
- Active
- Lots Status
- Active
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE UNIVERSITY OF BIRMINGHAM
- Contact Name
- Kseniya Samsonik
- Contact Email
- k.samsonik@bham.ac.uk
- Contact Phone
- Not specified
Buyer Location
- Locality
- BIRMINGHAM
- Postcode
- B15 2TT
- Post Town
- Birmingham
- Country
- England
-
- Major Region (ITL 1)
- TLG West Midlands (England)
- Basic Region (ITL 2)
- TLG3 West Midlands
- Small Region (ITL 3)
- TLG31 Birmingham
- Delivery Location
- TLG3 West Midlands
-
- Local Authority
- Birmingham
- Electoral Ward
- Edgbaston
- Westminster Constituency
- Birmingham Edgbaston
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-041a2f-2023-11-15T17:00:39Z",
"date": "2023-11-15T17:00:39Z",
"ocid": "ocds-h6vhtk-041a2f",
"initiationType": "tender",
"tender": {
"id": "SC12106/23",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Tender for the Supply of Services - Independent Central Review Of Primary Outcome Data For The GLO-BHNL Platform Clinical Trial - University Of Birmingham",
"status": "active",
"classification": {
"scheme": "CPV",
"id": "85150000",
"description": "Medical imaging services"
},
"mainProcurementCategory": "services",
"description": "The University of Birmingham invites tenders for independent central review of the primary outcome data for the clinical platform trial, Glo-BNHL. The platform aims to test a wide range of therapies over its lifetime in order to find better treatments for the rare paediatric cancer, B-cell non-Hodgkin's Lymphoma. The design allows addition of new treatment arms as novel therapies become available for testing. There are currently 2 treatment arms. Independent central review of the clinical data that informs the primary outcome measures is required, to include: cross sectional imaging by CT or MRI, PET-CT scan, bone marrow aspirate, bone marrow trephine and lumbar puncture pathology reports. Glo-BNHL is an international trial with participating sites in the UK, Europe, USA, Canada, Australia, New Zealand and Israel. A total of 45 sites will participate, with international sites' activity coordinated by 15 National Coordinating Centres. Glo-BNHL recently received ethics approval in the UK and will open later this year. Approval in the other participating nations will follow. An expedient solution to independent central review is therefore required. This project may be funded by the European Regional Development Fund (ERDF) or; - European Structural and Investment Fund (ESIF) or; - Research Councils UK (RCUK), the strategic partnership of the UK's seven Research Councils. Please refer to Appendix A via www.in-tendhost.co.uk/universityofbirmingham/aspx/Home for full specification of requirements.",
"value": {
"amount": 5000000,
"currency": "GBP"
},
"lots": [
{
"id": "1",
"description": "The University of Birmingham invites tenders for independent central review of the primary outcome data for the clinical platform trial, Glo-BNHL. The platform aims to test a wide range of therapies over its lifetime in order to find better treatments for the rare paediatric cancer, B-cell non-Hodgkin's Lymphoma. The design allows addition of new treatment arms as novel therapies become available for testing. There are currently 2 treatment arms. Independent central review of the clinical data that informs the primary outcome measures is required, to include: cross sectional imaging by CT or MRI, PET-CT scan, bone marrow aspirate, bone marrow trephine and lumbar puncture pathology reports. Glo-BNHL is an international trial with participating sites in the UK, Europe, USA, Canada, Australia, New Zealand and Israel. A total of 45 sites will participate, with international sites' activity coordinated by 15 National Coordinating Centres. Glo-BNHL recently received ethics approval in the UK and will open later this year. Approval in the other participating nations will follow. An expedient solution to independent central review is therefore required. This project may be funded by the European Regional Development Fund (ERDF) or; - European Structural and Investment Fund (ESIF) or; - Research Councils UK (RCUK), the strategic partnership of the UK's seven Research Councils. Please refer to Appendix A via www.in-tendhost.co.uk/universityofbirmingham/aspx/Home for full specification of requirements.",
"awardCriteria": {
"criteria": [
{
"name": "Compliance to the Specifications",
"type": "quality",
"description": "45"
},
{
"name": "After Sales and Technical back up",
"type": "quality",
"description": "15"
},
{
"name": "Delivery and Training",
"type": "quality",
"description": "15"
},
{
"name": "Sustainability and Environmental",
"type": "quality",
"description": "10"
},
{
"name": "Standard Supplier Questionnaire (SQ) Part 1 and Part 2",
"type": "quality",
"description": "10"
},
{
"type": "price",
"description": "5"
}
]
},
"contractPeriod": {
"startDate": "2024-03-30T00:00:00Z",
"endDate": "2031-03-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": false,
"status": "active"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UKG3"
}
],
"relatedLot": "1"
}
],
"submissionMethod": [
"electronicSubmission"
],
"submissionMethodDetails": "http://www.in-tendhost.co.uk/universityofbirmingham/aspx/Home",
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2023-12-15T12:00:00Z"
},
"submissionTerms": {
"languages": [
"en"
]
},
"awardPeriod": {
"startDate": "2023-12-15T12:01:00Z"
},
"bidOpening": {
"date": "2023-12-15T12:01:00Z"
},
"hasRecurrence": false
},
"parties": [
{
"id": "GB-COH-RC000645",
"name": "THE UNIVERSITY OF BIRMINGHAM",
"identifier": {
"legalName": "THE UNIVERSITY OF BIRMINGHAM",
"id": "RC000645",
"scheme": "GB-COH"
},
"address": {
"streetAddress": "Edgbaston",
"locality": "BIRMINGHAM",
"region": "UKG31",
"postalCode": "B152TT",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Kseniya Samsonik",
"email": "K.Samsonik@bham.ac.uk",
"url": "http://www.in-tendhost.co.uk/universityofbirmingham/aspx/Home"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.birmingham.ac.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "09",
"description": "Education"
}
]
}
},
{
"id": "GB-FTS-13761",
"name": "University of Birmingham",
"identifier": {
"legalName": "University of Birmingham"
},
"address": {
"locality": "Birmingham",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-COH-RC000645",
"name": "THE UNIVERSITY OF BIRMINGHAM"
},
"language": "en"
}